 |
The Journal of Neuroscience, June 15, 2005, 25(24):5815-5823; doi:10.1523/JNEUROSCI.1120-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Dopamine Specifically Inhibits Forebrain Neural Stem Cell Proliferation, Suggesting a Novel Effect of Antipsychotic Drugs
Tod E. Kippin,1
Shitij Kapur,2 and
Derek van der Kooy1
Departments of 1Medical Genetics and Microbiology and 2Psychiatry, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Neurogenesis has been implicated in antidepressant drug action and animal models of depression, suggesting that proliferating cells play a role in psychiatric disorders. Similar studies using antipsychotic drugs have yielded conflicting results, perhaps because of the lack of focus on specific cell types. We examine the effect of haloperidol on neural stem cells (NSCs), the ultimate precursors for adult cell genesis. We show that haloperidol increases NSC numbers, resulting in more progenitors and more new neurons and glia in the adult rat brain. The increase in NSCs by haloperidol is dependent on central dopamine D2 receptors, and these receptors are expressed by NSCs. D2 receptor stimulation in vitro inhibits NSC proliferation, which is reversed by haloperidol. Thus, haloperidol increases adult mammalian brain proliferation by antagonizing dopamine at D2 receptors on NSCs. These findings demonstrate a direct link between neural activity and NSC proliferation and implicate cell genesis in antipsychotic drug effects.
Key words: haloperidol; proliferation; dopamine receptor; dopamine; neuronal progenitor cell; neurogenesis; stem cells
Received Nov 15, 2004;
accepted April 27, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
T. Hagg
From Neurotransmitters to Neurotrophic Factors to Neurogenesis
Neuroscientist,
February 1, 2009;
15(1):
20 - 27.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al.
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Pharmacol. Rev.,
September 1, 2008;
60(3):
358 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mori, J. J. Jefferson, M. Hummel, and D. S. Garbe
CNTF: A Putative Link between Dopamine D2 Receptors and Neurogenesis
J. Neurosci.,
June 4, 2008;
28(23):
5867 - 5869.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yang, S. A. Arnold, A. Habas, M. Hetman, and T. Hagg
Ciliary Neurotrophic Factor Mediates Dopamine D2 Receptor-Induced CNS Neurogenesis in Adult Mice
J. Neurosci.,
February 27, 2008;
28(9):
2231 - 2241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Rashid, C. H. So, M. M. C. Kong, T. Furtak, M. El-Ghundi, R. Cheng, B. F. O'Dowd, and S. R. George
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum
PNAS,
January 9, 2007;
104(2):
654 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva
{micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors
J. Biol. Chem.,
November 3, 2006;
281(44):
33749 - 33760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. C. Batista, T. E. Kippin, S. Willaime-Morawek, M. K. Shimabukuro, W. Akamatsu, and D. van der Kooy
A Progressive and Cell Non-Autonomous Increase in Striatal Neural Stem Cells in the Huntington's Disease R6/2 Mouse
J. Neurosci.,
October 11, 2006;
26(41):
10452 - 10460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hu, M. C.-J. Cheeran, W. S. Sheng, H. T. Ni, J. R. Lokensgard, and P. K. Peterson
Cocaine Alters Proliferation, Migration, and Differentiation of Human Fetal Brain-Derived Neural Precursor Cells
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
1280 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Van Kampen and C. B. Eckman
Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.
J. Neurosci.,
July 5, 2006;
26(27):
7272 - 7280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Freundlieb, C. Francois, D. Tande, W. H. Oertel, E. C. Hirsch, and G. U. Hoglinger
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates.
J. Neurosci.,
February 22, 2006;
26(8):
2321 - 2325.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|